Bruker Corp BRKR
π Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2000-08-04 |
| Shares Out. | 152,230,000 |
| Website | bruker.com/ β |
| Phone | 13026365400 |
| Employees | 11,085 |
| Revenue | $838.5M |
| Gross Profit | $416.0M |
| Net Income | -$50.9M |
| Free Cash Flow | $64.5M |
| Total Assets | $6.05B |
| Total Liabilities | $3.62B |
| Equity | $2.40B |
About Bruker Corp
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Bruker Corp is a publicly traded company under the ticker symbol BRKR on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
21 analysts (2026-09-01)

